|
| Status |
Public on Jul 30, 2008 |
| Title |
CML Patient 1 7 days therapy |
| Sample type |
RNA |
| |
|
| Source name |
Peripheral Blood
|
| Organism |
Homo sapiens |
| Characteristics |
CD34+ cells of CML patient after 7 days of Glivec therapy
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Qiagen RNeasy mini kit (Qiagen; 74106)
|
| Label |
Biotin
|
| Label protocol |
GeneChip Expression 3’-Amplification One-Cycle-Target Labeling & Control Reagents
(Affymetrix; 900493)
|
| |
|
| Hybridization protocol |
According to manufacturers instructions
|
| Scan protocol |
According to manufacturers instructions
|
| Description |
(CML) chronic myeloid leukaemia / CD34+ stem cells after 7 days of Glivec therapy
|
| Data processing |
MAS 5.0, Scaling Factor 500
|
| |
|
| Submission date |
Jul 22, 2008 |
| Last update date |
Jul 29, 2008 |
| Contact name |
Daniela Bruennert |
| E-mail(s) |
Daniela.Bruennert@med.uni-duesseldorf.de
|
| Phone |
0211/8114869
|
| Organization name |
University Clinic Duesseldorf
|
| Department |
Clinic for Hematology, Oncology and clin. Immunology
|
| Lab |
Haematologisches Forschungslabor
|
| Street address |
Universitaetsstr. 1
|
| City |
Duesseldorf |
| ZIP/Postal code |
40225 |
| Country |
Germany |
| |
|
| Platform ID |
GPL571 |
| Series (1) |
| GSE12211 |
Gene expression of CML CD34+ cells during Imatinib therapy |
|
